Kaj Blennow
Impact in
- Psychiatry and Mental health top 0.01%
- Dementia and Cognitive Impairment Research
- Biological Psychiatry top 0.01%
- Tryptophan and brain disorders
Papers in
- Physiology 823
- Alzheimer's disease research and treatments 782
-
- Dementia and Cognitive Impairment Research 613
- Co-authors
- Henrik Zetterberg (251 shared papers)Oskar Hansson (208 shared papers)Harald Hampel (89 shared papers)Niklas Mattsson (154 shared papers)Ulf Andréasson (148 shared papers)Lennart Minthon (121 shared papers)Mony J. de Leon (25 shared papers)Eugeen Vanmechelen (72 shared papers)
- Journals
- Alzheimer s & Dementia (307 papers)Journal of Alzheimer s Disease (117 papers)Neurology (89 papers)Alzheimer s Research & Therapy (78 papers)Neurobiology of Aging (68 papers)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Kaj Blennow
2.0k papers receiving 124.1k citations
Kaj Blennow's Hit Papers
Peers
Comparison fields: 5 of 202
- Psychiatry and Mental health 33.8k
- Biological Psychiatry 5.3k
- Neurology 16.9k
- Physiology 50.4k
- Neurology 18.7k
Countries citing papers authored by Kaj Blennow
This map shows the geographic impact of Kaj Blennow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaj Blennow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaj Blennow more than expected).
Fields of papers citing papers by Kaj Blennow
This network shows the impact of papers produced by Kaj Blennow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaj Blennow. The network helps show where Kaj Blennow may publish in the future.
Co-authors
The 25 scholars most cited alongside Kaj Blennow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 2.1k papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Alzheimer's disease Hit paper breakdown → | 2006 | 2487 |
| 2 | Alzheimer's disease Hit paper breakdown → | 2016 | 2431 |
| 3 | Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects Hit paper breakdown → | 2009 | 1612 |
| 4 | Gut microbiome alterations in Alzheimer’s disease Hit paper breakdown → | 2017 | 1571 |
| 5 | CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis Hit paper breakdown → | 2016 | 1448 |
| 6 | Cerebrospinal fluid and plasma biomarkers in Alzheimer disease Hit paper breakdown → | 2010 | 1425 |
| 7 | Neurofilaments as biomarkers in neurological disorders Hit paper breakdown → | 2018 | 1353 |
| 8 | Alzheimer's disease Hit paper breakdown → | 2015 | 1306 |
| 9 | Clearance systems in the brain—implications for Alzheimer disease Hit paper breakdown → | 2015 | 1296 |
| 10 | Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study Hit paper breakdown → | 2006 | 1266 |
| 11 | The Amyloid-β Pathway in Alzheimer’s Disease Hit paper breakdown → | 2021 | 1219 |
| 12 | A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers Hit paper breakdown → | 2016 | 1210 |
| 13 | CSF markers for incipient Alzheimer's disease Hit paper breakdown → | 2003 | 981 |
| 14 | Neurofilament light chain as a biomarker in neurological disorders Hit paper breakdown → | 2019 | 853 |
| 15 | Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis Hit paper breakdown → | 2017 | 846 |
| 16 | Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia Hit paper breakdown → | 2020 | 801 |
| 17 | Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease Hit paper breakdown → | 2017 | 713 |
| 18 | Biomarkers for Alzheimer's disease: current status and prospects for the future Hit paper breakdown → | 2018 | 667 |
| 19 | Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group Hit paper breakdown → | 2021 | 641 |
| 20 | tau protein in cerebrospinal fluid Hit paper breakdown → | 1995 | 641 |
About Kaj Blennow
Kaj Blennow is a scholar working on Physiology, Psychiatry and Mental health, Molecular Biology, Neurology and Neurology, having authored 2.1k papers that have together received 125.9k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (782 papers), Dementia and Cognitive Impairment Research (613 papers), Neuroinflammation and Neurodegeneration Mechanisms (109 papers), S100 Proteins and Annexins (76 papers), Advanced Neuroimaging Techniques and Applications (71 papers), Parkinson's Disease Mechanisms and Treatments (71 papers), Neurological Disease Mechanisms and Treatments (70 papers) and Traumatic Brain Injury Research (67 papers). The work is most often cited by research in Psychiatry and Mental health (33.8k citations), Biological Psychiatry (5.3k citations), Neurology (16.9k citations), Physiology (50.4k citations) and Neurology (18.7k citations). Kaj Blennow has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Henrik Zetterberg, Oskar Hansson, Harald Hampel, Niklas Mattsson, Ulf Andréasson, Lennart Minthon, Mony J. de Leon, Eugeen Vanmechelen, Niels Andreasen and Pia Davidsson. Their work appears in journals such as Alzheimer s & Dementia, Journal of Alzheimer s Disease, Neurology, Alzheimer s Research & Therapy and Neurobiology of Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.